Our team
Meet our team
With over 100 years of combined experience building companies that has returned to shareholders over $3B over the course of working together.
George B.
Holmes
Chief Executive Officer
35+
Years of Executive, Sales & Marketing, Finance and Operations Leadership. Proven ability to lead companies that have returned over $3B in increased value to shareholders.
LinkedIn Profile
Martin
Martinov PhD
Chief Scientific Officer
30+
Years of Scientific Research & Drug Development. Leader in the development of core quantum bio-modeling algorithms
LinkedIn Profile
Dejan
Nenov
Chief Operating Officer
30+
Years of Executive, Engineering & Visionary Market Development Leadership. Proven Ability to Deliver Cutting Edge technical solutions
LinkedIn Profile
Todd
Meyerrose, PhD
President
15+
Med-tech entrepreneur with proven track record in developing companies from an idea to a successful exit.
LinkedIn Profile
John
Spinosa MD, PhD
Medical Director
30+
Medical Pathology expert and entrepreneur focused on building companies that can deliver best in class solutions for patients
LinkedIn Profile
Industry and Biomedical Science Experts
Luventix is privileged to have industry and biomed experts serving as advisors, bringing a wealth of experience and deep understanding of their respective sectors. These accomplished professionals play a pivotal role in providing strategic guidance, leveraging their technical acumen to help the company overcome barriers, make informed decisions, and accelerate growth. Their leadership and technical expertise help shape Luventix's development and success, making them invaluable members of the advisory board.
Osnat
Benshoshan
DTC & DTP Marketing
30+
Shaping companies’ go to market strategies, commercialization, leading complex strategic and operational initiatives
LinkedIn Profile
Oliver
Fiehn, PhD
Full Professor at UC Davis, Director West Coast Metabolomics Center, UC Davis Genome Center
25+
Biochemist with a focus on informatics solutions. Metabolism and omics-data interpretation. Nontargeted analyses in mass spectrometry.
Feihn Lab Profile
Allan
Hackshaw, MSc
Director of Cancer Research UK & UCL Cancer Trials Centre, University College London, & Professor of Epidemiology & Medical Statistics
30+
Expert in observational studies, clinical trials (phase I-III), & systematic reviews. Focus on adult/prenatal screening (cancer, genetic abnormalities). 200+ publications. Led groundbreaking prenatal screening studies & cancer trials. Evaluating multicancer blood tests. UK National Screening Committee member.
Dominic
Marasco
BioPharma & Entrepreneurial Executive, Advisor & Board Member
25+
Pharma/Biotech/Med Device executive. Expertise internationally in strategy, operations, business development, & finance. Success in P&L oversight, for-profit/non-profit, & start-up advisory.
LinkedIn ProfileTodd
Meyerrose, PhD
Healthcare Founder and Investor
15+
Med-tech entrepreneur with proven track record in developing companies from an idea to a successful exit.
LinkedIn ProfileJohn
Spinosa MD, PhD
Member College of American Pathologists (CAP), Healthcare Founder & Investor
30+
Medical Pathology expert and entrepreneur focused on building companies that can deliver best in class solutions for patients
LinkedIn Profile
David
Wishart, PhD
Distinguished University Professor, Depts. of Biological Sciences & Computing Science University of Alberta
25+
University of Alberta professor since 1995. Directs NRC Nano Life Science program. Expert in structural/nano/synthetic biology, prions, bioinformatics, metabolomics. Pioneered protein analysis techniques. Led Human Metabolome Project, cataloging 8000+ metabolites. Pioneered critical reference databases (Human Metabolome, DrugBank).
LinkedIn ProfileBusiness & Strategic Advisors
Luventix is fortunate to have business and strategic advisors who are seasoned experts, offering a wealth of experience and specialized knowledge. These accomplished professionals play a pivotal role in providing strategic guidance, leveraging their expertise to help the company overcome barriers, make informed decisions, and introductions that accelerate growth. Their leadership and strategic acumen are instrumental in shaping Luventix's development and success, making them invaluable members of the advisory board.
Marybeth
Carberry
Operations & Logistics
30+
Business Operations leadership, with focus on scale and efficiency, leading cross functional organizations through large transformational change.
LinkedIn Profile
Brett
Conrad
Advisor
35+
Finance: Capital Markets Expert, Hedge Fund Manager, consumer tech, clean tech and health tech. Operations: President Lululemon USA Inc, founder of multiple startups & exits. Health: Avid endurance athlete, 6x finisher Leadville 100 mile Mountain Bike Race
LinkedIn Profile
Jack
Jacobs
Capital Markets & Strategy
40+
Creating and expanding markets for both public and private companies. Leveraging both personal and public experience to mentor executives and drive value creation for shareholders
Wikipedia Profile
Marty
McDermut
Finance & Capital Markets
Jonathan
Rich
Capital Markets & Strategy
30+
Successfully guiding companies capital markets strategies, from fund raising to successful exits. Responsible for facilitating more than $6 billion in public and private financings and $2 billion in M&A across 500 companies in the healthcare, technology and consumer space.
LinkedIn ProfileIndustry Consultants
Luventix consultants are a group of professionals with specialized skills derived from a wealth of experience and specialized knowledge, playing a crucial role in providing strategic guidance and technical expertise to the company. These consultants, bring a unique combination of industry insight and specialized skills to the table, enabling them to deliver tailored solutions, drive innovation, and achieve tangible results.
